The most frequently mutated genes in human endometrial endometrioid cancer include the tumor suppressors PTEN and PIK3R1; the overwhelming majority of these cancers have abnormal activation of the PI3K/AKT signaling pathway [58,66,67]. The gene discussed is AKT1; the disease is neoplasm.